Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Chen W, Choi EJ, McDougall CM, Su H.

Transl Stroke Res. 2014 Jun;5(3):316-29. doi: 10.1007/s12975-014-0343-0. Epub 2014 Apr 12. Review.

2.

Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis.

Su H, Kim H, Pawlikowska L, Kitamura H, Shen F, Cambier S, Markovics J, Lawton MT, Sidney S, Bollen AW, Kwok PY, Reichardt L, Young WL, Yang GY, Nishimura SL.

Am J Pathol. 2010 Feb;176(2):1018-27. doi: 10.2353/ajpath.2010.090453. Epub 2009 Dec 17.

3.

Pathogenesis and radiobiology of brain arteriovenous malformations: implications for risk stratification in natural history and posttreatment course.

Achrol AS, Guzman R, Varga M, Adler JR, Steinberg GK, Chang SD.

Neurosurg Focus. 2009 May;26(5):E9. doi: 10.3171/2009.2.FOCUS0926. Review.

PMID:
19409010
4.

Prevalence of brain arteriovenous malformations in first-degree relatives of patients with a brain arteriovenous malformation.

van Beijnum J, van der Worp HB, Algra A, Vandertop WP, van den Berg R, Brouwer PA, van der Sprenkel JW, Kappelle LJ, Rinkel GJ, Klijn CJ.

Stroke. 2014 Nov;45(11):3231-5. doi: 10.1161/STROKEAHA.114.005442. Epub 2014 Sep 18.

5.

Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease.

Murphy PA, Lu G, Shiah S, Bollen AW, Wang RA.

Lab Invest. 2009 Sep;89(9):971-82. doi: 10.1038/labinvest.2009.62. Epub 2009 Jun 22. Erratum in: Lab Invest. 2009 Sep;89(9):1071.

6.

Embolization of residual fistula following stereotactic radiosurgery in cerebral arteriovenous malformations.

Hodgson TJ, Kemeny AA, Gholkar A, Deasy N.

AJNR Am J Neuroradiol. 2009 Jan;30(1):109-10. doi: 10.3174/ajnr.A1240. Epub 2008 Aug 7.

7.

Towards treatment planning for the embolization of arteriovenous malformations of the brain: intranidal hemodynamics modeling.

Orlowski P, Al-Senani F, Summers P, Byrne J, Noble JA, Ventikos Y.

IEEE Trans Biomed Eng. 2011 Jul;58(7):1994-2001. doi: 10.1109/TBME.2011.2119317. Epub 2011 Feb 24.

PMID:
21349788
8.

The Role of Macrophage in the Pathogenesis of Brain Arteriovenous Malformation.

Ma L, Guo Y, Zhao YL, Su H.

Int J Hematol Res. 2015 Jan 1;1(2):52-56. Epub 2015 Jul 6.

9.

Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations.

Pawlikowska L, Tran MN, Achrol AS, McCulloch CE, Ha C, Lind DL, Hashimoto T, Zaroff J, Lawton MT, Marchuk DA, Kwok PY, Young WL; UCSF BAVM Study Project.

Stroke. 2004 Oct;35(10):2294-300. Epub 2004 Aug 26.

10.

Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.

Zhang R, Zhu W, Su H.

Acta Neurochir Suppl. 2016;121:29-35. doi: 10.1007/978-3-319-18497-5_6.

11.

Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice.

Murphy PA, Lam MT, Wu X, Kim TN, Vartanian SM, Bollen AW, Carlson TR, Wang RA.

Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10901-6. doi: 10.1073/pnas.0802743105. Epub 2008 Jul 30.

12.

Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development.

Kim H, Pawlikowska L, Chen Y, Su H, Yang GY, Young WL.

Stroke. 2009 Mar;40(3 Suppl):S95-7. doi: 10.1161/STROKEAHA.108.533216. Epub 2008 Dec 8.

13.

Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO).

Pierot L, Cognard C, Herbreteau D, Fransen H, van Rooij WJ, Boccardi E, Beltramello A, Sourour N, Kupcs K, Biondi A, Bonafé A, Reith W, Casasco A.

Eur Radiol. 2013 Oct;23(10):2838-45. doi: 10.1007/s00330-013-2870-6. Epub 2013 May 8.

PMID:
23652849
14.

Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations.

Achrol AS, Pawlikowska L, McCulloch CE, Poon KY, Ha C, Zaroff JG, Johnston SC, Lee C, Lawton MT, Sidney S, Marchuk DA, Kwok PY, Young WL; UCSF BAVM Study Project.

Stroke. 2006 Jan;37(1):231-4. Epub 2005 Dec 1.

15.

Capillary malformation-arteriovenous malformation syndrome: a report of 2 cases, diagnostic criteria, and management.

Català A, Roé E, Vikkula M, Baselga E.

Actas Dermosifiliogr. 2013 Oct;104(8):710-3. doi: 10.1016/j.adengl.2012.04.025. Epub 2013 Aug 8.

PMID:
23933248
16.

The relationship of coexisting extranidal aneurysms to intracranial hemorrhage in patients harboring brain arteriovenous malformations.

Kim EJ, Halim AX, Dowd CF, Lawton MT, Singh V, Bennett J, Young WL.

Neurosurgery. 2004 Jun;54(6):1349-57; discussion 1357-8.

PMID:
15157291
17.

Natural history, evaluation, and management of intracranial vascular malformations.

Brown RD Jr, Flemming KD, Meyer FB, Cloft HJ, Pollock BE, Link ML.

Mayo Clin Proc. 2005 Feb;80(2):269-81. Review.

PMID:
15704783
18.

Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations.

Fullerton HJ, Achrol AS, Johnston SC, McCulloch CE, Higashida RT, Lawton MT, Sidney S, Young WL; UCSF BAVM Study Project.

Stroke. 2005 Oct;36(10):2099-104. Epub 2005 Sep 1.

19.

Endovascular treatment accounts for a change in brain arteriovenous malformation natural history risk.

Lv X, Wu Z, Jiang C, Li Y, Yang X, Zhang Y, Lv M, Zhang N.

Interv Neuroradiol. 2010 Jun;16(2):127-32. Epub 2010 Jul 19.

20.

Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations.

Hashimoto T, Wen G, Lawton MT, Boudreau NJ, Bollen AW, Yang GY, Barbaro NM, Higashida RT, Dowd CF, Halbach VV, Young WL; University of California, San Francisco BAVM Study Group.

Stroke. 2003 Apr;34(4):925-31. Epub 2003 Mar 20.

Items per page

Supplemental Content

Write to the Help Desk